Vesna Grivcheva-Panovska Selected Research

Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)

4/2021	Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
10/2020	Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus.
1/2020	Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.
1/2019	Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
1/2018	Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
9/2017	Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
8/2010	Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.
10/2009	Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vesna Grivcheva-Panovska Research Topics

Disease

7	Hereditary Angioedemas 04/2021 - 10/2009
3	Hypersensitivity (Allergy) 04/2021 - 09/2017
2	Angioedema 01/2018 - 10/2009
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 01/2022
1	Alopecia (Baldness) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Vitiligo 01/2022
1	Hyperhidrosis 01/2022
1	Prurigo 01/2022
1	Hidradenitis Suppurativa 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Acne Vulgaris 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Anaphylaxis (Anaphylactic Shock) 09/2017
1	Headache (Headaches) 09/2017
1	Fatigue 09/2017
1	Edema (Dropsy) 08/2010
1	Body Weight (Weight, Body) 10/2009
1	Vomiting 10/2009

Drug/Important Bio-Agent (IBA)

8	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 04/2021 - 10/2009
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2022
1	Pharmaceutical PreparationsIBA 04/2021
1	Neutralizing AntibodiesIBA 01/2019
1	berotralstatIBA 01/2018
1	acivicin (AT 125)IBA 01/2018
1	BradykininIBA 01/2018
1	Kallikreins (Kallikrein)IBA 01/2018
1	Plasma KallikreinIBA 01/2018
1	AntibodiesIBA 09/2017

Therapy/Procedure

1	Oral Administration 01/2018
1	Therapeutics 08/2010
1	Aftercare (After-Treatment) 10/2009